Quanticyt: Karyometric analysis of bladder washing for patients with superficial bladder cancer

被引:34
作者
vanderPoel, HG
Witjes, JA
vanStratum, P
Boon, ME
Debruyne, FMJ
Schalken, JA
机构
[1] UNIV NIJMEGEN HOSP,DEPT UROL,NL-6500 HB NIJMEGEN,NETHERLANDS
[2] LEIDEN CYTOL & PATHOL LAB,NL-2301 GB LEIDEN,NETHERLANDS
关键词
D O I
10.1016/S0090-4295(96)00210-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Quantitative cytology by image-analysis techniques enables objective interpretation of nuclear features in light microscopic images. OUANTICYT, a quantitative karyometric cytology system, was used in the follow-up of patients with superficial bladder cancer. Methods. From 1992 to 1995, 4137 samples from 1412 patients were obtained, At 1-year follow-up after the initial bladder washing, a tumor recurrence rate of 21% was found. In this period, tumor progression to invasive disease occurred in 1.6% of patients. Scoring of tumor by the QUANTICYT system was based on two nuclear features: the 2c deviation index and the mean of a nuclear shape feature: MPASS. Results. The method was found to be reproducible and superior to visual cytologic interpretation. QUANTICYT analysis of the bladder washings resulted in a score of low, intermediate, and high risk. In a multivariate analysis, highest grade of earlier tumor and OUANTICYT risk score were the best predictors of tumor recurrence and progression. For the easy application of OUANTICYT analysis in daily routine, a report form that included patient history and DNA histogram was developed. Conclusions, QUANTICYT karyometric analysis of bladder-wash material proved a useful, clinically applicable grading tool in the follow-up of patients with superficial bladder cancer, with sufficient power to be used in decision-making in the individual patient.
引用
收藏
页码:357 / 364
页数:8
相关论文
共 32 条
[1]   FLOW CYTOMETRIC EVALUATION OF BLADDER-CANCER - RECOMMENDATIONS OF THE NCI FLOW-CYTOMETRY NETWORK FOR BLADDER-CANCER [J].
AAMODT, RL ;
COON, JS ;
DEITCH, A ;
WHITE, RWD ;
KOSS, LG ;
MELAMED, MR ;
WEINSTEIN, RS ;
WHEELESS, LL .
WORLD JOURNAL OF UROLOGY, 1992, 10 (01) :63-67
[2]   SHOULD PT-1 TRANSITIONAL CELL CANCERS OF THE BLADDER STILL BE CLASSIFIED AS SUPERFICIAL [J].
ABEL, PD ;
HALL, RR ;
WILLIAMS, G .
BRITISH JOURNAL OF UROLOGY, 1988, 62 (03) :235-239
[3]   IMAGE CYTOMETRIC DEOXYRIBONUCLEIC-ACID ANALYSIS OF URINE SPECIMENS AS AN ADJUNCT TO VISUAL CYTOLOGY IN THE DETECTION OF UROTHELIAL CELL-CARCINOMA [J].
AMBERSON, JB ;
LAINO, JP .
JOURNAL OF UROLOGY, 1993, 149 (01) :42-45
[4]  
BADALAMENT RA, 1986, CANCER-AM CANCER SOC, V58, P2751, DOI 10.1002/1097-0142(19861215)58:12<2751::AID-CNCR2820581233>3.0.CO
[5]  
2-E
[6]  
BOCKING A, 1984, ANAL QUANT CYTOL, V6, P1
[7]  
BOWIE JE, 1977, ACTA CYTOL, V21, P455
[8]  
CANT JD, 1986, CANCER, V57, P2119, DOI 10.1002/1097-0142(19860601)57:11<2119::AID-CNCR2820571105>3.0.CO
[9]  
2-P
[10]  
COLLSTE LG, 1980, CANCER, V45, P2389, DOI 10.1002/1097-0142(19800501)45:9<2389::AID-CNCR2820450925>3.0.CO